NYSE · traded in Congress
Abbott Laboratories ABT
$111.4697 +1.5397 (+1.40%) Nov 9, 2026 4:12 AM ET
Chart
Analyst ratings
- 23 buy
- 8 hold
- 0 sell
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $13,013M | - | $920M | 7.1% | |
| $12,593M | - | $928M | 7.4% | |
| $11,164M | - | $1,077M | 9.7% | |
| $11,459M | - | $1,776M | 15.5% |
Congress trades in ABT
Members of Congress disclosed 17 transactions in ABT in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 10/02/2026 | Pete Sessions TX17 | Sale | $50,001 - $100,000 | 10/27/2026 filing |
| 09/18/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 10/12/2026 filing |
| 09/17/2026 | Thomas H. Kean NJ07 | Partial sale | $1,001 - $15,000 | 10/30/2026 filing |
| 07/30/2026 | Richard Dean Dr McCormick GA06 | Sale | $1,001 - $15,000 | 8/14/2026 filing |
| 07/17/2026 | Mike Kelly PA16 | Sale | $1,001 - $15,000 | 8/12/2026 filing |
| 07/14/2026 | Richard W. Allen GA12 | Sale | $15,001 - $50,000 | 8/18/2026 filing |
| 07/08/2026 | Rick Larsen WA02 | Sale | $1,001 - $15,000 | 7/12/2026 filing |
| 06/16/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 7/2/2026 filing |
| 06/12/2026 | Richard Dean Dr McCormick GA06 | Purchase | $1,001 - $15,000 | 7/9/2026 filing |
| 06/12/2026 | Richard Dean Dr McCormick GA06 | Purchase | $1,001 - $15,000 | 7/9/2026 filing |
| 05/27/2026 | Josh Gottheimer NJ05 | Partial sale | $1,001 - $15,000 | 6/3/2026 filing |
| 05/15/2026 | Gilbert Cisneros CA31 | Sale | $1,001 - $15,000 | 6/8/2026 filing |
| 05/12/2026 | Julie Johnson TX32 | Sale | $1,001 - $15,000 | 6/12/2026 filing |
| 04/16/2026 | Richard W. Allen GA12 | Sale | $15,001 - $50,000 | 6/5/2026 filing |
| 03/24/2026 | Laura Friedman CA30 | Exchange | $1,001 - $15,000 | 4/17/2026 filing |
| 03/19/2026 | Richard Dean Dr McCormick GA06 | Purchase | $1,001 - $15,000 | 4/7/2026 filing |
| 02/10/2026 | Gilbert Cisneros CA31 | Partial sale | $1,001 - $15,000 | 3/9/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.

